Holding Page
Holding Page
Request for Information – Commonsense Policy Options to Lower Drug Prices for Patients
August 17, 2026 The Honorable Ron Wyden Ranking Member, Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Re: Request for Information
CMS-4215-P – Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
August 17, 2026 The Honorable Mehmet Oz Administrator, Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services Attn: CMS-4215-P, P.O. Box
Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — Docket ID USTR-2026-0463
August 9, 2026 Ambassador Jamieson GreerUnited States Trade Representative600 17th Street NWWashington, DC 20508Re: Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — DocketID USTR-2026-0463Dear
PILMA Letter to HELP Committee: MAPIA
June 15, 2026 Dear Members of the Senate Committee on Health, Education, Labor and Pensions: The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition uniting the
PILMA Statement on MFN Drug Pricing Reconciliation Bill Amendment
May 20, 2026 The Pharmaceutical Industry Labor-Management Association (PILMA) issued the following statement in response to the potential inclusion of a Most Favored Nation drug
PILMA Letter on Senate HELP Drug Pricing Hearing
April 16, 2026 The Honorable Bill Cassidy, M.D. Chairman Committee on Health, Education, Labor, and Pensions United States Senate 428 Dirksen Senate Office Building Washington,
Request for Information – Commonsense Policy Options to Lower Drug Prices for Patients
August 17, 2026 The Honorable Ron Wyden Ranking Member, Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Re: Request for Information
CMS-4215-P – Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
August 17, 2026 The Honorable Mehmet Oz Administrator, Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services Attn: CMS-4215-P, P.O. Box
Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — Docket ID USTR-2026-0463
August 9, 2026 Ambassador Jamieson GreerUnited States Trade Representative600 17th Street NWWashington, DC 20508Re: Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — DocketID USTR-2026-0463Dear
PILMA Letter to HELP Committee: MAPIA
June 15, 2026 Dear Members of the Senate Committee on Health, Education, Labor and Pensions: The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition uniting the
PILMA Statement on MFN Drug Pricing Reconciliation Bill Amendment
May 20, 2026 The Pharmaceutical Industry Labor-Management Association (PILMA) issued the following statement in response to the potential inclusion of a Most Favored Nation drug
PILMA Letter on Senate HELP Drug Pricing Hearing
April 16, 2026 The Honorable Bill Cassidy, M.D. Chairman Committee on Health, Education, Labor, and Pensions United States Senate 428 Dirksen Senate Office Building Washington,